• About
    • Mission
    • Leadership
    • Careers
    • Clinical Advisory Board
    • News
    • Media & Press
    • Events
  • Viveve Solutions
    • Viveve System
    • InControl
  • Healthcare Providers
    • Clinical Studies
    • Become a Provider
    • Manage Your Listing
    • Hub Login
    • FAQs
    • Product Feedback
  • Patients
    • Blog
    • Find A Provider
    • Refer A Provider
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • FAQs
    • Viveve Hub
    • Submit a Product Experience
  • Product Indication
Select Page
Viveve | US

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Publications
    • IR Calendar
    • Analyst Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Clinical Advisory Board
    • Medical Consultants
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Investor Presentation
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Publications
  • IR Calendar
  • Analyst Coverage
  • Email Alerts

Viveve to Participate in H.C. Wainwright Global Investment Conference

May 17, 2022

Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report

May 17, 2022

Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 12, 2022

Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022

Apr 28, 2022

Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update

Mar 17, 2022

Viveve to Report Full Year 2021 Financial Results and Provide Corporate Update on March 17, 2022

Mar 3, 2022

Healthcare Technology Report Names Viveve Regulatory Executive Among Top 25 Women Leaders in Medical Devices

Jan 13, 2022

Viveve to Participate in H.C. Wainwright BIOCONNECT Conference

Jan 4, 2022

Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence

Dec 14, 2021

Viveve Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Nov 11, 2021
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...33

Viveve

A Global Women’s Intimate Health Company

Terms of Use | Privacy Policy
© 2022 Viveve Solutions. All Rights Reserved.

  • About
  • Viveve Solutions
  • Providers
  • Patients
  • Investors
  • Careers
  • Contact Us



  • Hub Login
  • Product Feedback

345 Inverness Drive South
Building B, Suite 250
Englewood, CO 80112

The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.

The Viveve® System is an internationally patented cryogen-cooled monopolar radiofrequency (CMRF) energy-based platform device. It has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

Translate »